Yeah, I Was Wrong

That’s a quote from the former Director of National Institute of Allergy and Infectious Diseases during his interview https://fortune.com/2023/03/21/anthony-fauci-pbs-american-masters-documentary-i-was-wrong/ on PBS

I think of this as his early farewell in Baltimore . https://twitter.com/MaryMargOlohan/status/1637831102109810693

It warmed my heart when what looked like his last hurrah fell flat.    “it took twenty years of science invested in this approach… ” said Fauci tacitly and he still got an argument that, as you will see down the page apiece, the man on the porch was right; they didn’t test it long enough.

Fauci was wrong again.

From https://covid19.nih.gov/news-and-stories/vaccine-development

Years before the COVID-19 pandemic began, experts at the NIH Vaccine Research Center (VRC) were studying coronaviruses to find out how to protect against them. The scientists chose to focus on one “prototype” coronavirus and create a vaccine for it. That vaccine could then be customized to fight different coronaviruses… 

Using their prototype coronavirus, the researchers studied the spike protein, which appears on the surface of coronaviruses. These spikes let the coronavirus latch onto cells in our body. When the body’s immune system sees the spike protein, it makes antibodies to try to protect the body from infection. This makes it a good vaccine target.

Traditionally, researchers would try putting the spike protein in the vaccine. When injected, the vaccine would stimulate a person’s immune system to protect them from a particular coronavirus. But the team knew that during a pandemic, it would take too long to make large amounts of a specific spike protein.

So, they studied a faster way to get a spike protein into the body. This new approach is to inject mRNA instructions for the spike protein into a person’s muscle. The muscle cells then make the spike protein. And then the body’s immune system makes the needed antibodies to protect itself.

Having this prototype approach, along with coronavirus research from labs around the world, made it possible for scientists to spring into action when the pandemic hit. Many vaccines take 10 to 15 years to reach the public. But the timeline for the COVID-19 vaccine was very different…

…The VRC worked with a company called Moderna to use this information to quickly customize their prototype approach to the SARS-CoV-2 spike protein. By early February, a COVID-19 vaccine candidate had been designed and manufactured. This vaccine is called mRNA-1273. By March 16, 2020, this vaccine had entered the first phase of clinical trials. Other vaccines, including a similar one from Pfizer and BioNTech SE, entered clinical trials not long after.

On December 18, 2020, after demonstrating 94 percent efficacy, the NIH-Moderna vaccine was authorized by the U.S. Food and Drug Administration (FDA) for emergency use. Just days earlier, the similar Pfizer/BioNTech vaccine had become the first COVID-19 vaccine to be authorized for use in the United States…

And again…

 https://www.clinmedjournals.org/articles/ijpcr/international-journal-of-pathology-and-clinical-research-ijpcr-8-137.php 

…LNP-incorporated mRNA comprises an enormous technological success that goes beyond vaccines, opening new avenues for developing “smart” therapeutics that can be delivered with pinpoint precision to specific subcellular structures [13]. The development of such therapeutics is anticipated to redefine clinical pathways, including for non-communicable diseases. However, are these therapies ready for worldwide application in their present molecular form?

The question has been asked before, often in relation to the potential toxicity of lipid formulations used in the past, especially as part of the delivering cancer therapeutics [14,15]. However, in the following sections, we take a closer look at a novel perspective, namely the mRNA vaccines’ structure and composition and at their unintended biological consequences derived from pathological cell-cell fusion…

As mRNA vaccines are based on pre-fusion epitopes, the fusion pathology may be undeterred, allowing viral infection by syncytia formation to continue unabated [3,16]. This is significant, as it could account for the reoccurrence of COVID-19 symptoms in fully vaccinated individuals [3,21,22]. In addition, this may explain the rare post-vaccination events associated with cell-cell fusion, including giant cell myocarditis, giant cell arthritis, and Creutzfeldt-Jakob Disease, recorded in Vaccine Adverse Event Reporting System (VAERS) database (please see section “Vaccine core: The synthetic mRNA”) [2327].

..PEG was added to the LNP to stabilize and prolong the mRNA duration of action (Figure 1). The extensive utilization of PEG over the past few decades, suggests that preexisting antibodies could trigger hypersensitivity to vaccines containing this molecule [54,55]. Aside from allergy, PEG is also an established chemical fusogen that can generate pathology by promoting polynucleation, aneuploidy, and genomic instability [5659]. In addition, PEG up regulates intracellular Ca2+, activating the transmembrane protein 16F (TMEM16F), a lipid scramblase that flips PS on the cell surface, triggering fusion, premature cellular senescence, and immunosuppression [6063]. As these phenotypes are virus-friendly, PEG-induced cell-cell fusion may inadvertently facilitate not only SARS-CoV-2 but also other viral infections [60,6466]. Furthermore, ePS-activated ADAM 10 and 17 promote syncytia formation via metalloprotease pathway [40,42,43]…

…The mRNA vaccines were approved on an emergency basis to combat COVID-19 pandemic. These vaccines also represent the first administration of LNPs at large scale. Taken together, they constitute milestones in the development of a novel and much promising therapeutics delivery field. Having said that, at the time of the emergency approval, the S2 viral antigen was insufficiently studied, and the FCS-mediated fusion pathology was mostly unknown. These aspects are now starting to attract attention, in an effort to best understand the underlying cellular mechanisms, pathways and potential unintended consequences.

 

And again…

https://www.nejm.org/doi/full/10.1056/NEJMe2106315

The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced with unprecedented speed with the use of diverse technologies. No major safety warnings, other than rare cases of anaphylaxis, were reported in the initial trials, which involved tens of thousands of adults, and the risk of serious adverse effects has remained remarkably low after vaccination of more than 400 million people worldwide to date.1

The New England Journal of Medicine must think 83,200 reported (03/10/23) adverse events resulting from a wrong decision and resulting in life changing damage is an acceptable investment for the billions of dollars the medical cabal collected during the scam.

https://news.yahoo.com/fauci-net-worth-nearly-doubled-154225312.html?

https://nypost.com/2022/10/03/non-profit-tied-to-wuhan-lab-gets-650k-more-to-study-coronaviruses/

The Vaccine Adverse Event Reporting System (VAERS) Results

Data current as of 03/10/2023 (copy & paste from the CDC website

 https://wonder.cdc.gov/controller/datarequest/D8

Total 83,200 100.00%

Michigan 11,277 13.55%

California 6,019 7.23%

Florida 5,757 6.92%

Minnesota 4,753 5.71%

Texas 4,153 4.99%

Cash was spread far and wide once the mistake was approved by science.

https://apnews.com/article/covid-business-health-europe-earnings-821499346af0ace177abf5aabfee9728 

The company posted net profit of nearly 3.2 billion euros ($3.6 billion) for the final three months of 2021, up from 367 million euros in the same period the previous year. Earnings per share rose to 12.18 euros from 1.43 euros a year ago.

https://seekingalpha.com/article/4554384-biontech-q3-earnings-management-tight-lipped-on-2023-covid-vaccine-revenues

Revenues of $3.5bn and operating profit of $2.4bn were impressive for a $37bn market cap company

But you ain’t seen tight lipped ’til you seen Pfizer…

https://www.sott.net/article/478484-Pfizer-CDC-withheld-evidence-of-myocarditis-after-COVID-shots-new-documents-reveal

with impressive gains coming from a government pushed mistake

https://www.cnbc.com/2023/01/31/the-covid-pandemic-drives-pfizers-2022-revenue-to-a-record-100-billion.html

You think they’re worried about being charged with anything serious?

They can handle whatever fine they accept for hiding the evidence against them.

And don’t be fooled… the scams aren’t over ’til the gangster’s in the can

https://www.msn.com/en-us/health/medical/the-fda-finally-admits-we-should-treat-covid-19-like-the-flu/ar-AAWTUgB

…this new reality will likely require annual COVID-19 shots to be tailored around the most threatening strains of the virus, the officials wrote.

See what I mean?

One thought on “Yeah, I Was Wrong”

Leave a Reply

Your email address will not be published. Required fields are marked *